CDER-2023-118739 Brand Name or Equal Biacore 1K+ upgrade kit

Closed Solicitation Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
FDA-RFQ-CDER-2023-118739-Brand-Name-or-Equal
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland 20993, United States

Notice details come from SAM.gov. Updated .

Notice text

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CDER-2023-118739 Biacore 1K+ upgrade kit- BNE -Brand Name or Equal, under solicitation FDA-RFQ-CDER-2023-118739-BNE. To continue to support the FDA mission, CDER is seeking to expand its current label-free Biacore surface plasmon resonance (SPR) systems.  The system shall be able to identify and measure molecular interactions of drugs and their biological receptors in a highly quantitative manner. FDA is looking to purchase a Biacore 1K+ SPR system upgrade with enhanced capabilities over the current Biacore T200 SPR, and which uses advanced intuitive software that will allow enhanced evaluation of SPR data to include interactive runs, potency assessments, and multi-complex analyses using poly-injections.   FDA seeks to purchase a BRAND NAME OR EQUIVALENT Biacore 1K+ SPR system upgrade.

Files

File Type Posted
FDA-RFQ-CDER-2023-118739-BNE.docx DOCX document

Notice history

Show all 13

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors